Global Financial Private Client’s Carnival Corporation Ltd CCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-208
Closed -$4.06K 445
2025
Q1
$4.06K Buy
208
+178
+593% +$4.23K ﹤0.01% 723
2024
Q4
$748 Buy
+30
New +$702 ﹤0.01% 838
2023
Q2
Sell
-22
Closed -$219 675
2023
Q1
$219 Sell
22
-200
-90% -$2.07K ﹤0.01% 667
2022
Q4
$1.79K Hold
222
﹤0.01% 565
2022
Q3
$1.52K Sell
222
-5,023
-96% -$48.7K ﹤0.01% 546
2022
Q2
$46.3K Hold
5,245
0.03% 268
2022
Q1
$105K Hold
5,245
0.05% 188
2021
Q4
$106K Sell
5,245
-2,199
-30% -$47K 0.05% 196
2021
Q3
$194K Hold
7,444
0.1% 143
2021
Q2
$196K Hold
7,444
0.11% 137
2021
Q1
$200K Hold
7,444
0.14% 114
2020
Q4
$161K Buy
7,444
+22
+0.3% +$391 0.13% 117
2020
Q3
$112K Buy
7,422
+262
+4% +$4.05K 0.1% 125
2020
Q2
$117K Buy
7,160
+246
+4% +$3.69K 0.1% 141
2020
Q1
$60.8K Buy
6,914
+6,714
+3,357% +$239K 0.06% 188
2019
Q4
$10.2K Buy
+200
New +$8.93K 0.01% 377

Other funds holding CCL

Global Financial Private Client's CCL Position: Q2 2025 in Review

Global Financial Private Client sold out of Carnival Corporation Ltd (CCL) in Q2 2025, closing a stake of 208 shares — an estimated $4.06K sold.

Global Financial Private Client first reported a position in CCL in Q4 2019 and held it in 16 quarters. The position peaked at $200K in Q1 2021. 1,002 funds tracked by Wall St. Rank hold CCL as of Q2 2025.

  • Global Financial Private Client reported no remaining Carnival Corporation Ltd position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 208 Carnival Corporation Ltd shares in Q2 2025, an estimated $4.06K.
  • Global Financial Private Client first reported a position in Carnival Corporation Ltd in Q4 2019 and held it in 16 quarters.
  • Global Financial Private Client's Carnival Corporation Ltd position peaked at $200K in Q1 2021.
  • 1,002 funds tracked by Wall St. Rank held Carnival Corporation Ltd as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.